Description
Overview
Targeted therapy for non-small cell lung cancer
Product Details
ERLOTINIB (Taro) 100 mg is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used in the treatment of metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer. It blocks EGFR signaling to inhibit tumor growth.
Key Benefits
- Clinically used and widely prescribed
- Supports effective symptom management
- Quality-controlled pharmaceutical product
How to Use
Use this medication exactly as prescribed by your healthcare provider. Dosage and duration depend on your condition and response to treatment.
Important Information
- Prescription may be required
- Consult your doctor before use
- Read the patient leaflet for full safety information
Reviews
There are no reviews yet.